Your browser doesn't support javascript.
loading
Design and Rationale of a Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy (COBRA-REDUCE).
Colleran, Róisín; Joner, Michael; Cutlip, Donald; Urban, Philip; Maeng, Michael; Jauhar, Rajiv; Barakat, Mark; Michel, Jonathan M; Mehran, Roxana; Kirtane, Ajay J; Maillard, Luc; Kastrati, Adnan; Byrne, Robert A.
Afiliação
  • Colleran R; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Joner M; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.
  • Cutlip D; Cardiology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
  • Urban P; La Tour Hospital, Geneva, Switzerland; CERC (Cardiovascular European Research Center), Massy, France.
  • Maeng M; Aarhus University Hospital, Aarhus, Denmark.
  • Jauhar R; North Shore University Hospital, Manhasset New York, NY, USA.
  • Barakat M; Celonova Biosciences Inc., San Antonio, TX, USA.
  • Michel JM; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Mehran R; Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
  • Kirtane AJ; Department of Medicine, Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, NY, United States of America; Cardiovascular Research Foundation, New York, NY, United States of America.
  • Maillard L; GCS-ES Axium-Rambot, Clinique Axium, Aix en Provence, France.
  • Kastrati A; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany. Electronic address: kastrati@dhm.mhn.de.
  • Byrne RA; Cardiovascular Research Institute Dublin, Mater Private Hospital, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons University of Medicine and Health Sciences, Dublin, Ireland. Electronic address: robert.byrne@materprivate.ie.
Cardiovasc Revasc Med ; 34: 17-24, 2022 01.
Article em En | MEDLINE | ID: mdl-33608239
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cardiovasc Revasc Med Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cardiovasc Revasc Med Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos